Evaluation of Different Staging System for Hepatocellular Cancer Patients Undergoing Radiotherapy

There is no agreement on predicting prognosis for malignant hepatoma patients undergoing actinotherapy. This study aims to guage the validity of various staging systems. Overall, 249 malignant hepatoma patients were evaluated retrospectively. All patients were classified by totally different staging systems. The additive survival rates were calculated victimisation the Kaplan-Meier technique, and survival curves were compared victimisation the log-rank take a look at. Harrell’s concordance index (c-index) was calculated. The 1-, 3-, and 5-year overall survival rates were fifty eight, thirty first and 2 hundredth, severally. important variations in overall survival were discovered between stages I and II of the Okuda staging system (p=0.004), between ample three and four of Cancer of the Liver Italian Program prognostic score (p=0.009), between Chinese University Prognostic Index low-risk and intermediate-risk teams (p=0.01), between one and a pair of points of the Japan Integrated Staging score (p=0.037), between stages III and IV of yankee Joint Committee on Cancer 1997 TNM staging system (p=0.011), between stages II and III of yankee Joint Committee on Cancer 2002 TNM staging system (p=0.026) and between stages I and II of Guangzhou 2001 staging system (p=0.000). finally, the Okuda staging system, Chinese University Prognostic Index, and Chinese Guangzhou 2001 staging system were additional discriminative than the opposite staging systems within the prognostic stratification for malignant hepatoma patients undergoing actinotherapy.

Leave a Comment

Your email address will not be published. Required fields are marked *